Cynomolgus IL-17A / CTLA-8 Protein, His Tag, low endotoxin (MALS verified)

  • TR-FRET Kit FRT-P011 is now available for advanced research.
Customer Reviews
Cat. No. / Size
Price
Qty
ILA-C5249-100ug
$410.00
ILA-C5249-1mg (250ug X 4)
$2875.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    IL-17A, Interleukin-17A, CTLA-8, IL-17

  • Source

    Cynomolgus IL-17A, His Tag (ILA-C5249) is expressed from human 293 cells (HEK293). It contains AA Gly 24 - Ala 155 (Accession # G7P4U9-1).

    Predicted N-terminus: His

    Request for sequence
  • Molecular Characterization

    IL-17A Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus.

    The protein has a calculated MW of 17.0 kDa. The protein migrates as 17-18 kDa,22-25 kDa and 27-28 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a dimer.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    IL-17A SDS-PAGE

    Cynomolgus IL-17A, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    IL-17A SEC-MALS

    The purity of Cynomolgus IL-17A, His Tag (Cat. No. ILA-C5249) is more than 95% and the molecular weight of this protein is around 34-55 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     IL-17A ELISA

    Immobilized Cynomolgus IL-17A, His Tag (Cat. No. ILA-C5249) at 2 μg/mL (100 μL/well) can bind Human IL-17 RA, Fc Tag (MALS verified) with a linear range of 0.2-3 ng/mL (QC tested).

    Protocol
  •  IL-17A ELISA

    Immobilized Cynomolgus IL-17A, His Tag (Cat. No. ILA-C5249) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL17A Antibody, Human IgG1 with a linear range of 0.1-0.8 ng/mL (Routinely tested).

    Protocol
  •  IL-17A ELISA

    Immobilized Cynomolgus IL-17A, His Tag (Cat. No. ILA-C5249) at 2 μg/mL (100 μL/well) can bind Human IL-17 RC, Fc Tag with a linear range of 10-80 ng/mL (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Interleukin-17A (IL17A) is also known as cytotoxic T-lymphocyte-associated antigen 8 (CTLA8),which is a proinflammatory cytokine produced by activated T cells. IL17A can regulate the activities of NF-kappaB and mitogen-activated protein kinases. Also,IL17A can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO).Furthermore,IL17A has been found both in glycosylated and nonglycosylated forms. High levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.

Recent Advances

 
Drug Development Progress
  • English Name:

    Interleukin 17A

  • Category:

  • Approved Drugs:

    5 Details

  • Drugs in Clinical Trials:

    35 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background